Melanoma Management最新文献

筛选
英文 中文
When to consider alternatives to front-line immune therapies in metastatic melanoma. 在转移性黑色素瘤中,何时考虑替代一线免疫疗法。
IF 3.6
Melanoma Management Pub Date : 2017-05-01 DOI: 10.2217/mmt-2017-0005
Daniel Y Wang, Douglas B Johnson
{"title":"When to consider alternatives to front-line immune therapies in metastatic melanoma.","authors":"Daniel Y Wang, Douglas B Johnson","doi":"10.2217/mmt-2017-0005","DOIUrl":"https://doi.org/10.2217/mmt-2017-0005","url":null,"abstract":"","PeriodicalId":44562,"journal":{"name":"Melanoma Management","volume":"4 2","pages":"71-74"},"PeriodicalIF":3.6,"publicationDate":"2017-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2217/mmt-2017-0005","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10752702","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Malignant melanoma of the small bowel presenting with intussusception in a woman: a case report. 女性小肠恶性黑色素瘤伴肠套叠一例报告。
IF 3.6
Melanoma Management Pub Date : 2017-05-01 Epub Date: 2017-05-15 DOI: 10.2217/mmt-2016-0028
Abby Vrable, Richard Chang
{"title":"Malignant melanoma of the small bowel presenting with intussusception in a woman: a case report.","authors":"Abby Vrable,&nbsp;Richard Chang","doi":"10.2217/mmt-2016-0028","DOIUrl":"https://doi.org/10.2217/mmt-2016-0028","url":null,"abstract":"<p><p>Primary malignant melanoma originating in the small bowel is very rare. We report the case of primary malignant melanoma of the small bowel with secondary intussusception in a 51-year-old female with no prior history of cutaneous melanoma. The patient was admitted to the hospital for clinical bowel obstruction after 6 months of varying symptoms of antecedent syncopal events secondary to profound anemia due to iron deficiency followed later by vomiting, abdominal pain and weight loss. A CT scan showed intussusception and she underwent a small bowel resection. Diagnosis of malignant melanoma was confirmed post-operatively following immunohistochemistry. The patient history and postoperative investigation excluded the existence of a primary lesion elsewhere. Our case represents an aggressive primary small bowel melanoma presenting as intussusception.</p>","PeriodicalId":44562,"journal":{"name":"Melanoma Management","volume":" ","pages":"99-104"},"PeriodicalIF":3.6,"publicationDate":"2017-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2217/mmt-2016-0028","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36468070","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Making melanoma therapy personal: an interview with Dr Keiran Smalley for Melanoma Management. 使黑色素瘤治疗个人化:采访Keiran Smalley博士为黑色素瘤管理。
IF 3.6
Melanoma Management Pub Date : 2017-05-01 Epub Date: 2017-05-19 DOI: 10.2217/mmt-2017-0001
Keiran Sm Smalley
{"title":"Making melanoma therapy personal: an interview with Dr Keiran Smalley for <i>Melanoma Management</i>.","authors":"Keiran Sm Smalley","doi":"10.2217/mmt-2017-0001","DOIUrl":"https://doi.org/10.2217/mmt-2017-0001","url":null,"abstract":"<p><p>Dr Smalley earned his PhD in Pharmacology from the University of Cambridge, UK, in 2001. He worked as a post-doctoral fellow in the Oncology Department of University College London, the Institute of Cancer Research, Fulham Road and the Wistar Institute, PA, USA. Currently, Dr Smalley is a Professor in the Departments of Tumor Biology and Cutaneous Oncology at the Moffitt Cancer Center, FL, USA. He is also currently the Donald A Adam Endowed Chair in Melanoma Research and is the Director of the Melanoma and Skin Cancers Center of Excellence. The lab of Dr Smalley focuses upon the development of targeted therapy strategies for melanoma and is currently funded by the NCI, the pharmaceutical industry and a number of philanthropic sources. Dr Smalley's work is highly translational in nature and work from his lab has led to the initiation of a number of clinical trials. To date, Dr Smalley has published over 120 papers in top peer-reviewed journals including Cancer Research, Cancer Discovery, Cancer Cell, New England Journal of Medicine, the Proceedings of the National Academy of Sciences, the Lancet, Gastroenterology and Clinical Cancer Research. He currently sits on the editorial boards of Clinical Cancer Research, Biochemical Pharmacology, Drugs, Melanoma Research and the American Journal of Clinical Dermatology and is the Associate Editor of Pharmacological Research. Dr Smalley is a charter member of the Basic Mechanisms of Cancer Therapeutics Study Section for the NCI/NIH and has served on many other peer review panels for the Department of Defense, the state of Texas and numerous melanoma research foundations. He has also fulfilled advisory roles with the University of Pennsylvania, the University of Pittsburgh and a number of pharmaceutical companies. Dr Smalley has been a visiting professor at the University of Sao Paulo, Brazil in 2011 and in 2014 received a Science Without Borders Scholarship from the Brazilian Government.</p>","PeriodicalId":44562,"journal":{"name":"Melanoma Management","volume":" ","pages":"95-97"},"PeriodicalIF":3.6,"publicationDate":"2017-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2217/mmt-2017-0001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36468069","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Patient perspective: life in the melanoma patient community and the emergence of the melanoma patient conference. 患者视角:黑色素瘤患者社区的生活和黑色素瘤患者会议的出现。
IF 3.6
Melanoma Management Pub Date : 2017-05-01 Epub Date: 2017-05-19 DOI: 10.2217/mmt-2017-0011
Imogen Cheese
{"title":"Patient perspective: life in the melanoma patient community and the emergence of the melanoma patient conference.","authors":"Imogen Cheese","doi":"10.2217/mmt-2017-0011","DOIUrl":"https://doi.org/10.2217/mmt-2017-0011","url":null,"abstract":"<p><p>Imogen Cheese speaks to Sebastian Dennis-Beron, Commissioning Editor: Imogen was diagnosed with melanoma in June 2013 (currently stage 2C no evidence of disease monitored under Professor Mark Middleton at Oxford) and has since created and writes a website blog (www.melanomarollercoaster.co.uk) as well as founded the melanoma patient conference in 2015. As an impartial event, the patient conference brings together all stakeholders involved in melanoma diagnosis, treatment and care; this includes clinicians, charities and crucially, people living and dying with melanoma. This means the only end goal for the conference are the ongoing needs of patients and families. Imogen's blog has a readership of over 2000 people - many of whom are melanoma patients in the UK. She is prolific in her contact with these patients on social media and as a result of her blog, she has been asked to represent melanoma patients in the UK as their advocacy representative at numerous conferences and events across Europe (including ECC2015 and the MPNE annual events in Brussels). Patients reach out to Imogen on a daily basis asking for support and seeking a means to improve their knowledge and obtain access to better care and information on the latest drugs and trials in the UK. She is a member of the Melanoma Patient Network Europe and speaks daily to over 300 patients on an online support group on social media. Imogen was invited by the British Skin Foundation to support them in establishing a skin cancer specific arm of their charity called ITTakes7 and has worked directly with Melanoma UK on various projects for patient interaction and information gathering. She is connected with Cancer Research UK as a patient representative with the ECMC network and involved with the Oxford hospitals as an advisor for their public engagement and planning. Imogen can be found on twitter at @MelanomaBlog.</p>","PeriodicalId":44562,"journal":{"name":"Melanoma Management","volume":" ","pages":"89-93"},"PeriodicalIF":3.6,"publicationDate":"2017-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2217/mmt-2017-0011","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36468068","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improving the diagnosis and treatment of acral melanocytic lesions. 提高肢端黑色素细胞病变的诊断和治疗水平。
IF 3.6
Melanoma Management Pub Date : 2017-05-01 Epub Date: 2017-05-19 DOI: 10.2217/mmt-2016-0017
Maressa C Criscito, Jennifer A Stein
{"title":"Improving the diagnosis and treatment of acral melanocytic lesions.","authors":"Maressa C Criscito,&nbsp;Jennifer A Stein","doi":"10.2217/mmt-2016-0017","DOIUrl":"https://doi.org/10.2217/mmt-2016-0017","url":null,"abstract":"<p><p>Melanocytic lesions of acral sites are common, with an estimated prevalence of 28-36% in the USA. While the majority of these lesions are benign, differentiation from acral melanoma (AM) is often challenging. AM is a unique subtype of melanoma, with distinct molecular characteristics that are thought to contribute to its high rate of locoregional recurrence and worse prognosis. The advent of dermoscopy has since improved the diagnostic accuracy of AM, resulting in earlier detection and arguably improved survival. Additionally, the identification of unique genomic amplifications in AM invites the potential for future AM-specific targeted therapies. Herein, we discuss the importance of dermoscopy in the diagnosis of acral melanocytic lesions and review the treatment strategies for AM.</p>","PeriodicalId":44562,"journal":{"name":"Melanoma Management","volume":" ","pages":"113-123"},"PeriodicalIF":3.6,"publicationDate":"2017-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2217/mmt-2016-0017","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36468072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 14
What is new in melanoma after European Cancer Congress 2017? 2017年欧洲癌症大会后黑色素瘤有什么新进展?
IF 3.6
Melanoma Management Pub Date : 2017-05-01 Epub Date: 2017-05-15 DOI: 10.2217/mmt-2017-0004
Piotr Rutkowski
{"title":"What is new in melanoma after European Cancer Congress 2017?","authors":"Piotr Rutkowski","doi":"10.2217/mmt-2017-0004","DOIUrl":"https://doi.org/10.2217/mmt-2017-0004","url":null,"abstract":"Department of Soft Tissue/Bone Sarcoma & Melanoma, Maria Sklodowska-Curie Institute – Oncology Center, Roentgena 5, 02–781 Warsaw, Poland; Tel.: +48 22 643 9375; Fax: +48 22 643 9791; piotr.rutkowski@coi.pl","PeriodicalId":44562,"journal":{"name":"Melanoma Management","volume":" ","pages":"83-87"},"PeriodicalIF":3.6,"publicationDate":"2017-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2217/mmt-2017-0004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36468067","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A surgical perspective report on melanoma management. 黑色素瘤治疗的外科视角报告。
IF 3.6
Melanoma Management Pub Date : 2017-05-01 Epub Date: 2017-05-15 DOI: 10.2217/mmt-2016-0031
Brian D Wernick, Neha Goel, Francis Sw Zih, Jeffrey M Farma
{"title":"A surgical perspective report on melanoma management.","authors":"Brian D Wernick,&nbsp;Neha Goel,&nbsp;Francis Sw Zih,&nbsp;Jeffrey M Farma","doi":"10.2217/mmt-2016-0031","DOIUrl":"https://doi.org/10.2217/mmt-2016-0031","url":null,"abstract":"<p><p>Management of melanoma includes wide excision with adequate margins and lymph node biopsy depending on the depth of the lesion, with subsequent completion lymphadenectomy for positive sentinel node. Locally advanced disease can be approached in several different ways depending on a variety of patient and disease-specific factors. These include surgical resection, isolated limb perfusion and infusion and intralesional injection therapy such as talimogene laherparepvec, IL-2 and Bacille Calmette-Guerin. Ongoing controversy exists regarding the utility of completion lymphadenectomy, and trials such as MSLT-2 will attempt to shed light on this issue. The future of melanoma management will likely focus on expanding the use of immunotherapy, allowing for narrower surgical margins, particularly in sensitive anatomic areas, and limiting the number of completion lymphadenectomies.</p>","PeriodicalId":44562,"journal":{"name":"Melanoma Management","volume":" ","pages":"105-112"},"PeriodicalIF":3.6,"publicationDate":"2017-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2217/mmt-2016-0031","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36468071","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Are we entering the era of combination therapy for melanoma? 我们是否进入了黑色素瘤联合治疗的时代?
IF 3.6
Melanoma Management Pub Date : 2017-03-01 DOI: 10.2217/mmt-2016-0029
Justine V Cohen, Ryan J Sullivan
{"title":"Are we entering the era of combination therapy for melanoma?","authors":"Justine V Cohen,&nbsp;Ryan J Sullivan","doi":"10.2217/mmt-2016-0029","DOIUrl":"https://doi.org/10.2217/mmt-2016-0029","url":null,"abstract":"","PeriodicalId":44562,"journal":{"name":"Melanoma Management","volume":"4 1","pages":"5-8"},"PeriodicalIF":3.6,"publicationDate":"2017-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2217/mmt-2016-0029","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36470213","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An interview with Giuseppe Argenziano: an insight into the field of dermoscopy. 采访朱塞佩·阿根齐亚诺:深入了解皮肤镜检查领域。
IF 3.6
Melanoma Management Pub Date : 2017-03-01 Epub Date: 2017-03-03 DOI: 10.2217/mmt-2016-0025
Giuseppe Argenziano
{"title":"An interview with Giuseppe Argenziano: an insight into the field of dermoscopy.","authors":"Giuseppe Argenziano","doi":"10.2217/mmt-2016-0025","DOIUrl":"https://doi.org/10.2217/mmt-2016-0025","url":null,"abstract":"<p><p><b>Giuseppe Argenziano speaks to Sebastian Dennis-Beron, Commissioning Editor:</b> Giuseppe Argenziano is Full Professor and Head of the Dermatology Unit at the University of Campania, Naples, Italy. His main research field is dermato-oncology. He is an author of numerous scientific articles and books concerning dermoscopy, a new technique improving the clinicians detection of benign and malignant skin tumors. As a coordinator of a Skin Cancer Unit, he has established a successful tertiary, multidisciplinary, referral center particularly devoted to the diagnosis and management of patients with skin tumors. Over the past 20 years he has supervised over 100 foreign students and 40 residents in dermatology, established scientific collaborations with more than 200 colleagues from more than 30 nations, and organized more than 50 national and international scientific activities, courses and conferences (such as the Consensus Net Meeting on Dermoscopy and the First Congress of the International Dermoscopy Society). He is co-founder and past president of the International Dermoscopy Society; project leader for the development of a high diagnostic technology oncologic center at the Arcispedale Santa Maria Nuova IRCCS in Reggio Emilia; faculty member of the Master of Science in Dermoscopy and Preventive Dermato-oncology and has undertaken a short course in dermoscopy, two e-learning courses by the Medical University of Graz and by Cardiff University, respectively; and member of the Editorial Board of the Journal of the American Academy of Dermatology. Professor Argenziano has authored more than 400 full scientific articles and produced landmark primary publications and books in the field of dermoscopy. Over the past 20 years, he has been invited as speaker and/or chairman in more than 500 national and international conferences in the field of dermatology. His combined publications have received a sum total of more than 8000 citations with an h-index value of 46.</p>","PeriodicalId":44562,"journal":{"name":"Melanoma Management","volume":"4 1","pages":"9-11"},"PeriodicalIF":3.6,"publicationDate":"2017-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2217/mmt-2016-0025","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36470214","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Welcome to the fourth volume of Melanoma Management and a look back at 2016. 欢迎收看《黑色素瘤管理》第四卷,回顾2016年。
IF 3.6
Melanoma Management Pub Date : 2017-03-01 Epub Date: 2017-03-03 DOI: 10.2217/mmt-2016-0033
Sebastian Dennis-Beron
{"title":"Welcome to the fourth volume of <i>Melanoma Management</i> and a look back at 2016.","authors":"Sebastian Dennis-Beron","doi":"10.2217/mmt-2016-0033","DOIUrl":"10.2217/mmt-2016-0033","url":null,"abstract":"","PeriodicalId":44562,"journal":{"name":"Melanoma Management","volume":"4 1","pages":"1-3"},"PeriodicalIF":3.6,"publicationDate":"2017-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2217/mmt-2016-0033","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36470211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信